TY - JOUR
TI - Satralizumab for neuromyelitis optica spectrum disorder
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2022
ET - 2021/12/10
VL - 45
IS - 1
DO - 10.18773/austprescr.2021.065
LA - eng
UR - https://australianprescriber.tg.org.au/articles/satralizumab-for-neuromyelitis-optica-spectrum-disorder.html
KW - Enspryng
KW - neuromyelitis optica spectrum disorder
KW - satralizumab
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -